A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...

Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...

The "personalized cancer vaccines" (PCVs) used by the nine patients in the trial were targeted to genes specific to their ...

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

In the latest study, researchers found the main genetic mutations in renal cell cancer, possibly by using artificial intelligence (AI). The scientists injected mRNA vaccine made against proteins ...

Groundbreaking personalized kidney cancer vaccines show promise in early clinical trials, triggering strong immune responses ...

Neoantigen-targeting personalized cancer vaccines (PCVs) are highly immunogenic in high-risk clear cell renal cell carcinoma ...

The advent of vaccinations came when a scientist, by the name of Edward Jenner, discovered that an individual exposed to a ...

生物医药行业近年来在癌症疫苗领域也获得多项进展。Moderna和默沙东联合开发的mRNA个体化癌症疫苗mRNA-4157正在多个后期临床试验中接受评估，治疗的癌症类型包括高危黑色素瘤、非小细胞肺癌、肾细胞癌、尿路上皮癌、皮肤鳞状细胞癌。它近日被行业媒 ...

Prescriptions of obesity management drugs (OMDs) have increased, and these increasing trends are associated with online ...